344 results on '"Poli, Giulio"'
Search Results
52. Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1 H)-One Scaffold.
53. Nuovi inibitori reversibili della monoacilglicerolo lipasi (MAGL) quali potenziali agenti antitumorali, antiinfiammatori e neuroprotettivi
54. Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study
55. An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)
56. Three-Dimensional Interactions Analysis of the Anticancer Target c-Src Kinase with Its Inhibitors
57. Aldose Reductase Differential Inhibitors in Green Tea
58. Shedding X-ray Light on the Role of Magnesium in the Activity of Mycobacterium tuberculosis Salicylate Synthase (MbtI) for Drug Design
59. Consensus Docking in Drug Discovery
60. Discovery of a new ATP-citrate lyase (ACLY) inhibitor identified by a pharmacophore-based virtual screening study
61. Application of MM-PBSA Methods in Virtual Screening
62. Antibacterial and ATP Synthesis Modulating Compounds from Salvia tingitana
63. 1,3-Dipolar Cycloaddition, HPLC Enantioseparation, and Docking Studies of Saccharin/Isoxazole and Saccharin/Isoxazoline Derivatives as Selective Carbonic Anhydrase IX and XII Inhibitors
64. New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents
65. Development of a cheminformatics platform for selectivity analyses of carbonic anhydrase inhibitors
66. The Extra-Virgin Olive Oil Polyphenols Oleocanthal and Oleacein Counteract Inflammation-Related Gene and miRNA Expression in Adipocytes by Attenuating NF-κB Activation
67. Synthesis and Biological Evaluation of New Glycoconjugated LDH Inhibitors as Anticancer Agents
68. Novel 8-Substituted Coumarins That Selectively Inhibit Human Carbonic Anhydrase IX and XII
69. Extensive Reliability Evaluation of Docking-Based Target-Fishing Strategies
70. First-of-its-kind STARD3 Inhibitor: In Silico Identification and Biological Evaluation as Anticancer Agent
71. Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor
72. Design, Synthesis, Docking Studies and Monoamine Oxidase Inhibition of a Small Library of 1-acetyl- and 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazoles
73. Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects
74. L-DOPA-quinone Mediated Recovery from GIRK Channel Firing Inhibition in Dopaminergic Neurons
75. Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
76. Discovery of a new ATP-citrate lyase (ACLY) inhibitor identified by a pharmacophore-based virtual screening study.
77. Development of a cheminformatics platform for selectivity analyses of carbonic anhydrase inhibitors.
78. Novel broad spectrum virucidal molecules against enveloped viruses
79. New diterpenes from Salvia pseudorosmarinus and their activity as inhibitors of monoacylglycerol lipase (MAGL)
80. Development of a Fingerprint-Based Scoring Function for the Prediction of the Binding Mode of Carbonic Anhydrase II Inhibitors
81. New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling Studies
82. Conformational Sampling of Small Molecules With iCon: Performance Assessment in Comparison With OMEGA
83. Identification of Lactate Dehydrogenase 5 Inhibitors using Pharmacophore- Driven Consensus Docking
84. Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides
85. Anticancer Activity of Euplotin C, Isolated from the Marine Ciliate Euplotes crassus, Against Human Melanoma Cells
86. Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors
87. An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)
88. Three-Dimensional Analysis of the Interactions between hLDH5 and Its Inhibitors
89. Largazole Analogues as Histone Deacetylase Inhibitors and Anticancer Agents: An Overview of Structure-Activity Relationships
90. 3D Pharmacophore Modeling Techniques in Computer‐Aided Molecular Design Using LigandScout
91. Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors
92. Application of a FLAP-Consensus Docking Mixed Strategy for the Identification of New FAAH Inhibitors
93. Shedding X-ray Light on the Role of Magnesium in the Activity of Mycobacterium tuberculosisSalicylate Synthase (MbtI) for Drug Design
94. Rutin as promising drug for the treatment of Parkinson's disease: an assessment of MAO-B inhibitory potential by docking, molecular dynamics and DFT studies.
95. First-of-its-kind STARD3 Inhibitor: In Silico Identification and Biological Evaluation as Anticancer Agent.
96. Drug Affinity Responsive Target Stability (DARTS) Identifies Laurifolioside as a New Clathrin Heavy Chain Modulator
97. Reliability analysis and optimization of the consensus docking approach for the development of virtual screening studies
98. A Virtual Screening Study for Lactate Dehydrogenase 5 Inhibitors by Using a Pharmacophore-based Approach
99. Novel broad spectrum virucidal molecules against enveloped viruses.
100. Identification of a new STAT3 dimerization inhibitor through a pharmacophore-based virtual screening approach
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.